Serotiny
- Total Funding$3 M
OverviewSuggest Edit
Serotiny is a company that is engaged in the discovery of proteins for cell therapies. It focuses on such proteins as CARs (chimeric antigen receptors) for the treatment of cancers and genetic disorders.
| Type | Private | |
| Founded | 2014 | |
| Website | serotiny.bio |
Latest Updates
| Employees (est.) (Jun 2022) | 12 | (-7%) |
| Cybersecurity rating | A | More |
Serotiny Financials and Metrics
Summary Metrics
Founding Date | 2014 |
Serotiny total Funding | $3 m |
Serotiny latest funding size | $3 m |
Time since last funding | 4 years ago |
Serotiny investors | NanoDimension, 8VC |
Serotiny's latest funding round in July 2018 was reported to be $3 m. In total, Serotiny has raised $3 m
Serotiny Cybersecurity Score
Serotiny Online and Social Media Presence
74 Twitter followers
Serotiny has 74 Twitter Followers. The number of followers has increased 1% month over month and increased 7.1% quarter over quarter
Serotiny's Trends
Twitter Engagement Stats for @serotinybio
9
Tweets
35
Following
74
Followers
2
Tweets last 30 days
2.5
Avg. likes per Tweet
100%
Tweets with engagement
Serotiny Frequently Asked Questions
When was Serotiny founded?
Serotiny was founded in 2014.
How many employees does Serotiny have?
Serotiny has 12 employees.
Who are Serotiny competitors?
Competitors of Serotiny include Redbiotec, Kelonia Therapeutics and Instil Bio.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies